KEI Industries Limited (BOM:517569)
India flag India · Delayed Price · Currency is INR
3,811.55
-30.55 (-0.80%)
At close: Aug 1, 2025

Sage Therapeutics Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2021
102,61297,35981,20769,08257,27041,815
Upgrade
Revenue Growth (YoY)
22.39%19.89%17.55%20.63%36.96%-14.45%
Upgrade
Cost of Revenue
79,50075,18162,15853,22443,64130,817
Upgrade
Gross Profit
23,11222,17819,05015,85713,62910,999
Upgrade
Selling, General & Admin
3,7053,5823,1312,5992,3492,046
Upgrade
Other Operating Expenses
9,0288,6067,3486,1555,3414,364
Upgrade
Operating Expenses
13,55812,96911,1169,3878,2967,021
Upgrade
Operating Income
9,5549,2087,9346,4705,3343,978
Upgrade
Interest Expense
-446.95-443.5-308.8-240.47-227.66-359.77
Upgrade
Interest & Investment Income
519.15519.15212.68166.7220.2843.25
Upgrade
Earnings From Equity Investments
----0.351
Upgrade
Currency Exchange Gain (Loss)
101.87101.8755.1866.6199.36113.39
Upgrade
Other Non Operating Income (Expenses)
187.04-75.82-112.34-42.02-157.96-192.9
Upgrade
EBT Excluding Unusual Items
9,9159,3107,7806,4215,0683,583
Upgrade
Gain (Loss) on Sale of Investments
-0.01-0.01----
Upgrade
Gain (Loss) on Sale of Assets
6.916.910.890.430.26-1.01
Upgrade
Asset Writedown
-0.09-0.09-4.02-20.71-0.68-0.27
Upgrade
Other Unusual Items
---3.4---
Upgrade
Pretax Income
9,9759,3707,8116,4205,0753,605
Upgrade
Income Tax Expense
2,5552,4062,0021,6471,315908.57
Upgrade
Earnings From Continuing Operations
7,4196,9645,8084,7733,7602,696
Upgrade
Earnings From Discontinued Operations
---1.15---
Upgrade
Net Income to Company
7,4196,9645,8074,7733,7602,696
Upgrade
Minority Interest in Earnings
--0.110.040.06-1.02
Upgrade
Net Income
7,4196,9645,8074,7733,7602,695
Upgrade
Net Income to Common
7,4196,9645,8074,7733,7602,695
Upgrade
Net Income Growth
21.70%19.92%21.66%26.95%39.50%5.17%
Upgrade
Shares Outstanding (Basic)
939290909190
Upgrade
Shares Outstanding (Diluted)
939290909191
Upgrade
Shares Change (YoY)
3.41%1.97%0.11%-0.98%0.68%10.24%
Upgrade
EPS (Basic)
79.4575.6564.3752.9441.4430.04
Upgrade
EPS (Diluted)
79.3675.5564.2552.8641.4429.76
Upgrade
EPS Growth
17.68%17.59%21.54%27.55%39.25%-4.58%
Upgrade
Free Cash Flow
--7,2982,1064,1641,7011,299
Upgrade
Free Cash Flow Per Share
--79.1823.3046.1218.6514.34
Upgrade
Dividend Per Share
-4.0003.5003.0002.5002.000
Upgrade
Dividend Growth
-14.29%16.67%20.00%25.00%33.33%
Upgrade
Gross Margin
22.52%22.78%23.46%22.96%23.80%26.30%
Upgrade
Operating Margin
9.31%9.46%9.77%9.37%9.31%9.51%
Upgrade
Profit Margin
7.23%7.15%7.15%6.91%6.57%6.45%
Upgrade
Free Cash Flow Margin
--7.50%2.59%6.03%2.97%3.11%
Upgrade
EBITDA
10,1529,7888,4436,9645,8264,494
Upgrade
EBITDA Margin
9.89%10.05%10.40%10.08%10.17%10.75%
Upgrade
D&A For EBITDA
597.88580.13509.15493.52492.49515.71
Upgrade
EBIT
9,5549,2087,9346,4705,3343,978
Upgrade
EBIT Margin
9.31%9.46%9.77%9.37%9.31%9.51%
Upgrade
Effective Tax Rate
25.62%25.67%25.64%25.65%25.91%25.20%
Upgrade
Revenue as Reported
103,59398,07781,53169,40057,41642,016
Upgrade
Advertising Expenses
-478.25404.96215.19276.81129.77
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.